Goldman Sachs executive’s email making plea for racial equality goes viral at firm
June 5, 2020
Asia’s stock rally pause ahead of U.S. jobs data, euro at 1-1/2 month top
June 5, 2020

KKR, Ampersand Capital in joint bid for Oxford Immunotec: sources

A consortium of private equity firms KKR & Co Inc and Ampersand Capital Partners has approached Oxford Immunotec Global Plc , a medical diagnostics company that develops tests to identify tuberculosis, with a $400 million acquisition offer, people familiar with the matter said on Thursday.

Powered by WPeMatico